| Dr Daniel David Martin, MD | |
|
21000 E 12 Mile Rd Ste 111, Saint Clair Shores, MI 48081-1156 | |
| (586) 779-7610 | |
| (586) 779-7685 |
| Full Name | Dr Daniel David Martin |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 8 Years |
| Location | 21000 E 12 Mile Rd Ste 111, Saint Clair Shores, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902250921 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 4301503926 (Michigan) | Secondary |
| 207YS0012X | Otolaryngology - Sleep Medicine | 4301503926 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St John Hospital | Detroit, MI | Hospital |
| Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group Michigan | 0648180406 | 105 |
| Ascension St John Hospital | 3173424082 | 296 |
News Archive
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients with Alpha-1 antitrypsin deficiency (AATD), a life-threatening genetic disorder, according to a new study presented at the 2013 American Thoracic Society International Conference.
Frederick A. Gulmi, MD, chief of urology at NYU Lutheran, cautions anyone who has never had a bout with kidney stones.
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Insulet Corporation, a Massachusetts-based medical device company, has gone live with Pilgrim's On-Demand "SaaS" delivery of its automated management solution for Corrective and Preventive Action (CAPA) management.
Celgene International Sàrl today announced that researchers presented data from an investigator-initiated Phase II study of lenalidomide (REVLIMID) in untreated patients with chronic lymphocytic leukemia at the annual meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Entity Name | Ascension St John Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043478910 PECOS PAC ID: 3173424082 Enrollment ID: O20040115000409 |
News Archive
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients with Alpha-1 antitrypsin deficiency (AATD), a life-threatening genetic disorder, according to a new study presented at the 2013 American Thoracic Society International Conference.
Frederick A. Gulmi, MD, chief of urology at NYU Lutheran, cautions anyone who has never had a bout with kidney stones.
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Insulet Corporation, a Massachusetts-based medical device company, has gone live with Pilgrim's On-Demand "SaaS" delivery of its automated management solution for Corrective and Preventive Action (CAPA) management.
Celgene International Sàrl today announced that researchers presented data from an investigator-initiated Phase II study of lenalidomide (REVLIMID) in untreated patients with chronic lymphocytic leukemia at the annual meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Entity Name | Ascension Medical Group Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114133485 PECOS PAC ID: 0648180406 Enrollment ID: O20081015000289 |
News Archive
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients with Alpha-1 antitrypsin deficiency (AATD), a life-threatening genetic disorder, according to a new study presented at the 2013 American Thoracic Society International Conference.
Frederick A. Gulmi, MD, chief of urology at NYU Lutheran, cautions anyone who has never had a bout with kidney stones.
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Insulet Corporation, a Massachusetts-based medical device company, has gone live with Pilgrim's On-Demand "SaaS" delivery of its automated management solution for Corrective and Preventive Action (CAPA) management.
Celgene International Sàrl today announced that researchers presented data from an investigator-initiated Phase II study of lenalidomide (REVLIMID) in untreated patients with chronic lymphocytic leukemia at the annual meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel David Martin, MD 21000 E 12 Mile Rd Ste 111, Saint Clair Shores, MI 48081-1156 Ph: (586) 779-7610 | Dr Daniel David Martin, MD 21000 E 12 Mile Rd Ste 111, Saint Clair Shores, MI 48081-1156 Ph: (586) 779-7610 |
News Archive
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients with Alpha-1 antitrypsin deficiency (AATD), a life-threatening genetic disorder, according to a new study presented at the 2013 American Thoracic Society International Conference.
Frederick A. Gulmi, MD, chief of urology at NYU Lutheran, cautions anyone who has never had a bout with kidney stones.
Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Insulet Corporation, a Massachusetts-based medical device company, has gone live with Pilgrim's On-Demand "SaaS" delivery of its automated management solution for Corrective and Preventive Action (CAPA) management.
Celgene International Sàrl today announced that researchers presented data from an investigator-initiated Phase II study of lenalidomide (REVLIMID) in untreated patients with chronic lymphocytic leukemia at the annual meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
Dr. Douglas Carl Kubek, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd, Ste 111, Saint Clair Shores, MI 48081 Phone: 586-779-7610 Fax: 586-779-1391 | |
Dr. Andrew Bennett Sewell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd Ste 111, Saint Clair Shores, MI 48081 Phone: 586-779-7610 Fax: 586-779-0031 | |
Dr. Michael S Fozo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd, Suite 111, Saint Clair Shores, MI 48081 Phone: 586-779-7610 | |
Dr. Andrew I. Dzul, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 21000 E 12 Mile Rd, Suite 111, Saint Clair Shores, MI 48081 Phone: 586-779-7610 | |
Dr. Adam D Rubin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd, Suite 111, Saint Clair Shores, MI 48081 Phone: 586-779-7610 | |
Dr. Robert E Brammer, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 21000 E 12 Mile Rd, Suite 111, Saint Clair Shores, MI 48081 Phone: 586-779-7610 | |
Cameron M Heilbronn, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd Ste 111, Saint Clair Shores, MI 48081 Phone: 586-779-7610 Fax: 586-779-7882 |